| Literature DB >> 33928363 |
Hee-Ju Nah1, Jihee Park1, Sisun Choi1, Eung-Soo Kim1.
Abstract
Streptomyces species are soil-dwelling bacteria that produce vast numbers of pharmaceutically valuable secondary metabolites (SMs), such as antibiotics, immunosuppressants, antiviral, and anticancer drugs. On the other hand, the biosynthesis of most SMs remains very low due to tightly controlled regulatory networks. Both global and pathway-specific regulators are involved in the regulation of a specific SM biosynthesis in various Streptomyces species. Over the past few decades, many of these regulators have been identified and new ones are still being discovered. Among them, a global regulator of SM biosynthesis named WblA was identified in several Streptomyces species. The identification and understanding of the WblAs have greatly contributed to increasing the productivity of several Streptomyces SMs. This review summarizes the characteristics and applications on WblAs reported to date, which were found in various Streptomyces species and other actinobacteria.Entities:
Keywords: zzm321990 Streptomyceszzm321990 ; Secondary metabolite regulation; WhiB-like gene A (wblA)
Mesh:
Substances:
Year: 2021 PMID: 33928363 PMCID: PMC9113171 DOI: 10.1093/jimb/kuab007
Source DB: PubMed Journal: J Ind Microbiol Biotechnol ISSN: 1367-5435 Impact factor: 4.258
WblA orthologs identified from various Streptomyces species
| Gene | Strain | Size | Identity (with WblAsco) | Compounds | SM production in DIS mutant (fold) | References |
|---|---|---|---|---|---|---|
| WblAsco | 112 aa | 100% | Actinorhodin | Increased (5.6-fold) | Lee et al. ( | |
| WblAspe | 114 aa | 95% | Doxorubicin, daunorubicin | Increased (1.7-fold) | Kang et al. ( | |
| WblAtmc | 130 aa | 96% | Tautomycetin | Increased (3.2-fold) | Nah et al. ( | |
| WblAgh | 128 aa | 96% | Moenomycin A | Increased (2.3-fold) | Rabyk et al. ( | |
| Increased (2.5-fold) | Yan et al. ( | |||||
| WblAsro | 116 aa | 90% | Daptomycin | Increased (1.5-fold) | Huang et al. ( | |
| WblAsan | 112 aa | 96% | Nikkomycin (major) | Abolished | Lu et al. ( | |
| Tylosin analogs (cryptic) | Activated | |||||
| WblAso | 124 aa | 85% | Violapyrone | Increased (NR) | Huang et al. ( | |
| WblAsve | 115 aa | 90% | Pikromycin | Increased (3.5-fold) | Yan et al. ( | |
| WblAscb | 131 aa | 93% | Tiancimycins | Increased (13.9-fold) | Nguyen et al. ( |
SM, secondary metabolite; DIS, disruption; NR, not reported.
Fig. 1.WblAs phylogenetic tree among Streptomyces species. Phylogenetic tree was built using the Mega X software by neighbor joining test by Bootstrap. WblA from S. coelicolor; wblA from S. peucetius; wblA from Streptomyces sp. CK4412; wblA from S. ghanaensis; wblA from S. roseosporus; wblA from S. ansochromogenes; wblA from S. somaliensis; wblA from S. venezuelae; wblA from Streptomyces sp. CB03234; wblA from S. avermitilis; and wblA from S. griseus.
Fig. 2.Sequence alignments among the Streptomyces WblAs. Conserved (asterisk) and related (colon) amino acids were marked underneath. Gray box; cysteine conserved region.
Fig. 3.Regulatory network of WblA controlled by AdpAsc in S. coelicolor. ACT, actinorhodin; RED, undecylprodigiocin; CDA, calcium-dependent antibiotic.